OriginalFungemias en hospitales de la Ciudad de Buenos Aires, ArgentinaFungemia in hospitals of the City of Buenos Aires, Argentina
Section snippets
Materiales y métodos
Se realizó un estudio multicéntrico prospectivo y observacional de las fungemias basado en datos de laboratorio entre enero de 2005 y diciembre de 2008. Los centros asistenciales fueron 16 hospitales integrantes de la Red de Micología de la Ciudad de Buenos Aires: 9 hospitales generales, 3 hospitales universitarios, 2 hospitales pediátricos, un hospital de enfermedades infecciosas y un hospital de enfermedades respiratorias.Trece hospitales aportaron sus datos durante todo el período del
Resultados
Del 1-01-2005 al 31-12-2008 se procesaron 190.920 hemocultivos (182.050 automatizados y 8.870 por lisis-centrifugación).
En 1.020 hemocultivos hubo recuperación de elementos fúngicos (tabla 1). La incidencia global de fungemias fue 1,72 episodios por 1.000 ingresos hospitalarios. Hubo 683 episodios por Candida, 214 por Cryptococcus, 105 por Histoplasma capsulatum y 18 episodios por otros agentes fúngicos, entre los cuales se encontraban 7 fungemias por Rhodotorula, 5 por Trichosporon, 2 por
Discusión
Este análisis prospectivo, basado en el diagnóstico del laboratorio durante 4 años, constituye el mayor estudio multicéntrico de la ciudad capital de la República Argentina. Si bien no es un estudio poblacional, permite conocer datos que reflejan lo que sucede en la ciudad de Buenos Aires.
La incidencia global de fungemias fue 1,72 episodios por 1.000 ingresos hospitalarios. No se detectaron diferencias significativas en el curso de los 4 años estudiados.
La incidencia de las candidemias en el
Conflicto de intereses
Los autores declaran no tener ningún conflicto de intereses.
Bibliografía (40)
- et al.
The aging innate immune system
Curr Opin Immunol
(2005) - et al.
Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005)
Rev Iberoam Micol
(2009) - et al.
Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006
J Microbiol Immunol Infect
(2010) - et al.
Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009)
Diagn Microbiol Infect Dis
(2010) - et al.
Candidemia in French hospitals: incidence rates and characteristics
Clin Microbiol Infects
(2002) - et al.
Barcelona Candidemia Project Study Group. Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain
Clin Microbiol Infect
(2010) - et al.
Invasive candidiasis: an overview from Taiwan
J Formos Med Assoc
(2009) - et al.
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
J Clin Microbiol
(2005) - et al.
Comparative study of three blood culture systems for the diagnosis of systemic mycoses associated with AIDS
J Mycol Med
(1997) - et al.
The usefulness of blood culture in diagnosing HIV-related systemic mycoses: evaluation of a manual lysis centrifugation method
Med Mycol
(2000)
Candidaemia in patients with an inserted medical device
Drugs
Active surveillance for candidemia, Australia
Emerg Infect Dis
Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven Medical Centers
J Clin Microbiol
High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility
Scand J Infect Dis
Nosocomial bloodstream infections in United States hospitals: a three-year analysis
Clin Infect Dis
Yeast identification in the clinical microbiology laboratory: phenotypical methods
Med Mycol
Evaluation of BACTEC MYCO/F Lytic Medium for recovery of mycobacteria, fungi and bacteria from blood
J Clin Microbiol
Attributable mortality of nosocomial candidemia, revisited
Clin Infect Dis
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry
Clin Infect Dis
Cited by (19)
Diagnostic efficacy of serum cytokines and chemokines in patients with candidemia and bacteremia
2020, CytokineCitation Excerpt :While the AUROC, sensitivity and specificity of combining MIP-1β and G-CSF were 0.896 (95% CI: 0.792–0.939), 82.4% and 84.5%, respectively. With the extensive use of broad-spectrum antibiotics, the increase of immunosuppressive population and development of invasive treatment technology, the incidence of fungal bloodstream infection rise gradually in the past decade [8]. Currently, successful treatment of fungal infection requires cooperation of entire health care team, thus systemic therapy should be applied once the diagnosis is defined.
Cryptococcosis in an Infectious Diseases Hospital of Buenos Aires, Argentina. Revision of 2041 cases: Diagnosis, clinical features and therapeutics
2018, Revista Iberoamericana de MicologiaCitation Excerpt :C. neoformans (genotype VNI) has been isolated in most of the cases. On numerous occasions the blood culture, as well as skin or respiratory cultures, made the diagnosis possible.10,46,57,58 The use of sunflower agar in primary cultures has been of great help in these cases.
Performance evaluation of Rapid™ yeast plus (Remel) system from two different culture media
2016, Revista Argentina de MicrobiologiaEvaluation of the VITEK 2 system (AST-YSO1 cards) for antifungal susceptibility testing against different Candida species
2014, Revista Argentina de MicrobiologiaEvaluation of Vitek 2 for the identifi cation of Candida yeasts
2014, Revista Argentina de MicrobiologiaEpidemiology of candidaemia and invasive candidiasis. A changing face
2014, Revista Iberoamericana de MicologiaCitation Excerpt :This species predominates in candidaemias reported from Australia, Latin America and the Mediterranean countries of Africa, Asia and Europe. C. parapsilosis is usually susceptible to most antifungal agents, but there are reports of clinical isolates with decreased susceptibility to azoles and echinocandins.1–3,10–16,23–26,38,40,43–48,52,60 C. glabrata and C. krusei are associated with recent major abdominal surgery, solid tumours, old patients (>65 years), neutropaenic neonates, transplant recipients, and patients treated with corticoids.1,10,45,48,60
- ◊
Los componentes del grupo están relacionados en el anexo.